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Timing of birth is a major determinant of newborn health. African American women are at increased 
risk for early birth, particularly via the inflammatory pathway. Variants of the IL1RN gene, which 
encode the interleukin-1 receptor antagonist (IL-1Ra) protein, are implicated in early birth. The 
biological pathways linking these variables remain unclear. Evidence also suggests that inflammatory 
pathways differ by race; however, studies among African American women are lacking. 
Objectives  
We assessed whether an IL1RN variant was associated with timing of birth among African American 
women and whether this relationship was mediated by lower anti-inflammatory IL-1Ra production or 
related to a decrease in inhibition of proinflammatory IL-1β production. 
Methods  
A candidate gene study using a prospective cohort design was used. We collected blood samples at 28–
32 weeks of gestation among African American women experiencing an uncomplicated pregnancy (N = 
89). IL1RN single-nucleotide polymorphism (SNP) rs2637988 was genotyped, and lipopolysaccharide-
stimulated IL-1Ra and IL-1β production was quantified. Medical record review determined timing of 
birth. 
Results  
Women with GG genotype gave birth earlier than women with AA/AG genotypes (b* = .21, p = .04). 
There was no indirect effect of IL1RN SNP rs2637988 allele status on timing of birth through IL-1Ra 
production, as evidenced by a nonsignificant product of coefficients in mediational analyses (ab = .006, 
95% CI [−0.05, 0.13]). Women with GG genotype showed less inhibition of IL-1β production for a unit 
positive difference in IL-1Ra production than women with AA/AG genotypes (b* = .93, p = .03). Greater 
IL-1β production at 28–32 weeks of pregnancy was marginally associated with earlier birth (b* = 
.21, p = .05). 
Discussion  
Women with GG genotype may be at risk for earlier birth because of diminished IL-1β inhibition, 
allowing for initiation of a robust inflammatory response upon even mild immune challenge. Study of 
inflammatory contributions to early birth among African American women may be key to identifying 
potential prognostic markers of risk and targeted preventive interventions. 
 
Timing of birth is a major determinant of health across the lifespan (Behrman & Stith Butler, 2007). 
Compared to those born full term (39–40 weeks), babies born early as well as late are at increased risk 
for morbidity and mortality (Matthews, MacDorman, & Thoma, 2015; Morken, Klungsøyr, & Skjaerven, 
2014; Seikku et al., 2016). Early birth is particularly prevalent among African American women; U.S. 
rates of birth before full term reach 32.0% among White women compared to 40.4% among African 
American women (Hamilton, Martin, Osterman, Curtin, & Matthews, 2015). Improved methods to 
prevent early birth and eliminate racial disparities in early birth are sorely needed; however, the 
maternal biological underpinnings driving early birth, particularly among African American women, are 
not fully understood. 
It has recently been appreciated that early birth is best characterized as a syndrome preceded by 
several major instigating biological pathways, including inflammation, hypothalamic–pituitary–adrenal 
axis activation, and decidual hemorrhage (Manuck et al., 2015; Myatt et al., 2012). African American 
women, specifically, appear to be most susceptible to early birth via the inflammatory pathway (Frey et 
al., 2016; Menon et al., 2009). Indeed, inflammatory responses are tightly regulated during pregnancy 
(Christian & Porter, 2014; Gillespie, Porter, & Christian, 2016) and, like the alternative instigating 
pathways, inflammation ultimately promotes the classical signs and symptoms of labor: cervical 
dilation, uterine contraction, and rupture of fetal membranes (Romero, Dey, & Fisher, 2014; Shynlova, 
Lee, Srikhajon, & Lye, 2013). 
Given these data and the estimated 24%–34% heritability of timing of birth (Kistka et al., 2008; W. Wu 
et al., 2015), genetic variants with inflammatory implications have been of considerable interest in the 
study of early birth. Interestingly, genetic variants within the IL1RN gene, which encodes the anti-
inflammatory interleukin-1 receptor antagonist (IL-1Ra) protein, have been more consistently 
implicated in early birth than genetic variants within the IL-1β gene, which directs production of 
proinflammatory IL-1β (Cui, Wang, Zhang, & Liu, 2015; Dolan et al., 2010; Jones et al., 2012; Yilmaz et 
al., 2012). However, among African American women, elevated peripheral and amniotic fluid IL-1β 
levels but not diminished IL-1Ra levels have been found among those experiencing preterm versus 
term labor (Brou et al., 2012; Gabay, Lamacchia, & Palmer, 2010; Menon, Williams, & Fortunato, 
2007; Velez et al., 2008). Therefore, the biological processes linking IL1RN genetic variants to timing of 
birth, particularly among African American women, are not immediately clear. Furthermore, the role 
that natural antagonists play in limiting proinflammatory activity in pregnancy is considerably 
understudied. 
Among nonpregnant populations, IL1RN genetic variants are associated with risk for diseases marked 
by inflammation (Benke et al., 2011; He, Peng, Xiong, Xu, & Liu, 2015; Korthagen, van Moorsel, 
Kazemier, Ruven, & Grutters, 2012; X. Wu et al., 2013). As previously discussed, enhanced 
inflammation is also thought to play a large role in expediting the onset of labor. Among White 
samples, disease-associated IL1RN tagging polymorphisms (e.g., IL1RN single nucleotide polymorphism 
[SNP] rs2637988) appear to impact risk by lowering IL-1Ra expression (Korthagen et al., 2012). It is 
unclear whether this pathway holds in the development of early labor, particularly among African 
American women. Alternatively, IL1RN genetic variants may decrease the ability of IL-1Ra to 
competitively inhibit proinflammatory IL-1β production during an inflammatory immune response, 
with IL-1β ultimately influencing timing of birth. Furthermore, IL1RN gene association studies have 
typically enrolled heterogeneous cohorts and analyzed data without racial stratification (e.g., Cui et al., 
2015), highlighting a critical need to determine whether associations among IL1RN genetic variants and 
timing of birth hold among African American women. 
To extend the current literature, we evaluated whether a tagging variant of the IL1RN gene, SNP 
rs2637988, was associated with timing of birth among generally healthy African American women. We 
also aimed to delineate the biological processes that may link the IL1RN variant to timing of birth. We 
evaluated whether the relationship between IL1RN SNP rs2637988 allele status and timing of birth was 
mediated by lower IL-1Ra production (Figure 1A). As an alternative hypothesis, we evaluated whether 
IL1RN SNP rs2637988 allele status affected the inhibition of IL-1β production by IL-1Ra during the 
inflammatory immune response, with IL-1β production, in turn, associated with timing of birth (Figure 
1B). 
 
FIGURE 1: Conceptual diagrams of pathways linking interleukin-1 receptor antagonist (IL-1RN) genetic variants 
with timing of birth. Panel A shows the indirect effect of IL1RN SNP rs2637988 allele status (X) on days gestation 
at birth (Y) through IL-1Ra production (M). Panel B shows the effect of IL-1Ra production (X) on IL-1β production 
(Y) conditional on IL1RN SNP rs2637988 allele status (Z), as well as the effect of IL-1β production (X) on days 
gestation at birth (Y). Boxes outlined with dashes list potentially confounding variables. IL = interleukin; Ra = 
receptor antagonist; SNP = single-nucleotide polymorphism. 
METHODS 
Study Design and Participants 
African American women of non-Hispanic ethnicity aged 18–35 and carrying a single-fetus pregnancy 
were recruited from two obstetrics/gynecology (OB/GYN) clinics and the greater Columbus, Ohio, 
community. Given the potential for error in estimation of due date according to last menstrual period 
alone or by ultrasound in later pregnancy, confirmation or determination of due date by ultrasound 
performed at ≤15 weeks gestation was required for study participation (American College of 
Obstetricians and Gynecologists, 2014). Women were excluded if they reported tobacco, alcohol, or 
illicit drug use beyond the first trimester, a chronic immune-impacting condition (e.g., diabetes, 
rheumatoid arthritis), regular use of medications with immune implications (e.g., corticosteroids, 
progesterone), or experienced a complication of pregnancy with known immune implications (i.e., 
gestational diabetes or preeclampsia; Chaiworapongsa, Chaemsaithong, Yeo, & Romero, 2014; Lekva, 
Norwitz, Aukrust, & Ueland, 2016). Women diagnosed with fetal anomaly were also not eligible for 
enrollment. 
The protocol for the study was approved by the institutional review boards of The Ohio State 
University and OhioHealth. Informed consent and Health Insurance Portability and Accountability Act 
(HIPAA) authorization were obtained from all participating women. Enrollment occurred from 
September 2013 to June 2015. Preliminary results are published as an abstract (Gillespie, Neal, et al., 
2016). 
Following a prospective cohort design and a candidate gene approach, women attended a single study 
visit between 28 weeks 0 days and 32 weeks 6 days gestation, at which time they were not 
experiencing symptoms of preterm labor (N = 96). Women reporting current cold- or flu-like illness or 
antibiotic use prior to the visit were rescheduled at least 7 days removed but still within the gestational 
age window. During the study visit, interviews were performed and blood was drawn. To reduce the 
influence of diurnal variation on immune function, venipuncture was standardized to occur between 
11:00 A.M. and 4:00 P.M. for all women (Curtis & Fagundes, 2016). After women gave birth, prenatal, 
labor and delivery, and newborn medical records were reviewed. This approach allowed establishment 
of a time sequence of the assessed mediational pathway, with inheritance of stable genetic attributes 
acquired prior to measurement of the inflammatory immune response, which also precedes the timing 
of birth outcome. Of the women enrolled, two were removed because of unsuccessful venipuncture, 
one was removed because she provided an incorrect estimated due date leading to blood sampling 
outside the study window, one woman was lost to follow-up, and three women developed 
preeclampsia following enrollment. Therefore, analyses were performed on a final sample of 89 
women. 
Variables and Measurement 
Sample Characteristics 
Demographic characteristics were determined by self-report. Obstetric history, complications of the 
current pregnancy, and circumstances of labor and birth were extracted from the medical records. 
DNA Purification and Allelic Discrimination 
K2EDTA-treated whole blood was stored in aliquots at −80°C until processed in batches. At this time, 
blood was quick-thawed in a 37°C water bath and deoxyribonucleic acid (DNA) was extracted and 
purified using PCR DNA Column Kits according to manufacturer instructions (5 Prime, Gaithersburg, 
MD). DNA concentration and purity were determined using the Nanodrop 2000 (Thermo Scientific, 
Wilmington, DE), and samples were diluted to reach a final concentration of 20 ng of DNA per well. 
Allelic discrimination was performed, in duplicate, using probe-based TaqMan SNP Genotyping Assays 
and Master Mix (Applied Biosystems, Foster City, CA), amplification by polymerase chain reaction, and 
the CFX96 Touch Real-Time PCR Detection System (Bio-Rad, Hercules, CA). Allele calls were made by 
examining relative fluorescence units for each allele and required corresponding discrimination for 
each of the duplicate wells. 
IL-1Ra and IL-1β Production 
IL-1Ra and IL-1β production were determined using a highly standardized stimulation protocol based 
on the methods of Hall et al., (2013). Within 1 hour of collection, 50 μl of heparinized whole blood was 
aliquoted under sterile conditions into a 500-μl lipopolysaccharide (LPS) solution; that is, 500 pg LPS 
from Salmonella abortus equi S-form (Enzo Life Sciences, Ann Arbor, MI) per 1 ml RPMI medium (MP 
Biomedicals, Santa Ana, CA). This procedure was also repeated using RPMI medium alone to produce a 
control condition. Cultures were incubated at 37°C for 4 hours and centrifuged at 3,000 RPM for 5 
minutes. Supernatants were aspirated and stored in aliquots at −80°C until thawed in batches. IL-1Ra 
levels were determined using the Human IL-1Ra Platinum ELISA (eBiosciences, San Diego, CA) and 
PowerWave Spectrophotometer (BioTek, Winooski, VT) per manufacturer instructions. Intra- and inter-
assay coefficients of variation were 9.4% and 17.2%, respectively. IL-1β levels were determined using 
the MSD Proinflammatory II 4-plex Immunoassay and Sector Imager 2400 per manufacturer 
instructions (Meso Scale Discovery, Gaithersburg, MD). Intra- and inter-assay coefficients of variation 
were 6.1% and 4.5%, respectively. For each analyte, production was calculated by subtracting the 
quantity produced in the control condition from the quantity produced in the LPS-stimulated 
condition. Undetectable control values were set at the lower limit of detection for the appropriate 
assay. 
Timing of Birth 
Timing of birth was operationalized as days gestation at birth. Days gestation at birth was calculated by 
considering the estimated due date and actual date of birth, each extracted from the medical record. 
Estimated due dates were assigned by providers per usual care, with all participants assigned a due 
date per ultrasound determination or confirmation at ≤15 weeks gestation. For example, a birth 
occurring on the expected due date was assigned a value of 280 days (i.e., 40 weeks) gestation. 
Statistical Analyses 
Sample characteristics and descriptive statistics were examined according to mean and standard 
deviation (SD) or count and percentage as appropriate. For all analyses, IL1RN SNP rs2637988 allele 
status was dichotomized as lacking minor allele A (i.e., GG genotype) versus possessing minor allele A 
(i.e., AA/AG genotypes). Hardy–Weinberg equilibrium of the genetic data was assessed using χ2 tests 
(α = .05). Spearman rank order correlations among IL-1Ra production, IL-1β production, and days 
gestation at birth were examined. Potentially confounding variables were identified by examining 
bivariate associations among IL1RN SNP rs2637988 allele status, IL-1 Ra production, IL-1β production, 
days gestation at birth, and sample characteristics using Student’s t-tests, χ2 tests for independence, or 
Fisher’s exact tests with α at .05 and controlled as appropriate. 
First, a linear regression model was fit to test the association between IL1RN SNP rs2637988 allele 
status (X) and days gestation at birth (Y; yi = b0 + b1xi + ei), where b0 is the intercept, ei is error in the 
estimation of yi, and b1 is the coefficient assigned to the predictor in estimation of the outcome 
(H0: β1 = 0; H1: β1 ≠ 0). Because of nonnormality and heteroskedasticity of error terms, days gestation 
at birth (Y) was transformed by reflecting the negatively skewed variable (i.e., −[days gestation] + 288 + 
1) and taking the square root of the reflected value. X was coded as 0 = IL1RN SNP rs2637988 
AA/AG and 1 = IL1RN SNP rs2637988 GG, so b1 gives the change in transformed value of days gestation 
at birth associated with the GG genotype. 
Next, the framework and process of Hayes (2013) was applied to test the proposed mediational 
pathway. Linear regression models were used to evaluate the indirect effect of IL1RN SNP rs2637988 
allele status (X) coded as described above, on days gestation at birth (Y), transformed as described 
above, through IL-1Ra production (M; conceptually depicted in Figure 1A). The effect of X on M was 
estimated (Mediational Model 1: mi = b0 + a1xi+ ei) followed by the effect of M on Y controlling for X 
(Mediational Model 2: yi = b0 + c′1xi + b1mi + ei). Here, a1, b1, and c1 are the coefficients assigned to 
each predictor in the estimation of the respective outcome. The indirect effect was quantified as the 
product of a1 and b1. Inference was achieved by constructing 10,000 bias-corrected bootstrap 
confidence intervals, with replacement, with support for a statistically significant indirect effect 
stemming from a confidence interval that did not contain 0 (H0 for mediation: Ta1 Tb1 = 0; H1 for 
mediation: Ta1 Tb1 ≠ 0, where the subscript T indicates the true value of the coefficient). 
The effect of IL-1Ra production (X) on IL-1β production (Y) conditional on IL1RN SNP rs2637988 allele 
status (Z; conceptually depicted in Figure 1B) was also estimated using a linear regression model 
(Conditional Model: yi = b0 + b1xi + b2zi + b3xizi + ei), where b1, b2, and b3 are the coefficients 
assigned to each predictor in the estimation of the outcome (H0 for moderation: β2 = 0; H1 for 
moderation: β3 ≠ 0). Because of nonnormality and heteroskedasticity of error terms, IL-1β production 
(Y) was transformed by taking the square root of the positively skewed variable. Finally, a linear 
regression model was fit to test the association between IL-1β production (X) and the transformed 
value of days gestation at birth (Y; yi = b0 + b1xi + ei; H0: β1 = 0; H1: β1 ≠ 0). 
Residual, leverage, and influence diagnostics were examined for each model. No observation had a 
Cook’s distance greater than 1, which corresponds to a distance beyond a 50% confidence interval 
between the vector of the estimated regression coefficient with and without the observation included 
in the model (Cook & Weisberg, 1982). SPSS 22.0 (New York, NY) was used to run the Hayes process to 
test the mediational pathway whereas STATA 12.0 (College Station, TX) was used for all other analyses. 
RESULTS 
Sample Characteristics 
Characteristics of the sample, descriptive statistics, and comparisons by IL1RN SNP rs2637988 allele 
status (i.e., GG genotype vs. AA/AG genotypes) are summarized in Table 1. Mean days gestation at 
birth fell at 273.8 days (39 weeks 0.8 days [SD = 9.2 days; Mdn = 275 days; range: 239–288 days]). 
Among the 89 women, 31 (34.8%) gave birth before full term (39 weeks) and 5 (5.6%) gave birth before 
term (37 weeks). A total of 36 (40.4%) women in our sample underwent induction or prelabor cesarean 
section, which is slightly lower than typical U.S. rates (Hamilton et al., 2015; MacDorman, Declercq, & 
Zhang, 2010; Zhang et al., 2010). Induction or prelabor cesarean section was rare before full term (n = 
7; 7.9%). 
TABLE 1: Sample Characteristics and Comparisons by IL1RN SNP rs2637988 Allele Status 
 All (n 
= 89) 
 GG (n = 
25) 
 AA or AG (n = 
64) 
  
Characteristic n (% )  n (% )  n (% )  pa 
Marital status 
(unmarried/separated) 
67 (75.3) 19 (76.0) 48 (75.0) .92 
Maternal education (<bachelor’s) 65 (73.0) 17 (68.0) 48 (75.0) .50 
Insurance (private not reported) 59 (66.3) 15 (60.0) 44 (68.7) .43 
Parity (multiparous) 61 (68.5) 17 (68.0) 44 (68.8) .95 
Birth before term (previous, no) 81 (91.0) 23 (92.0) 58 (90.6) .60 
Contractions/rupture (yes)b 53 (59.6) 15 (60.0) 38 (59.4) .98 
Method of delivery (vaginal)c 44 (83.0) 14 (93.3) 30 (78.9) .20 
Induction of labor (yes)b 19 (21.3) 5 (20.0) 14 (21.9) .98 
Primary indication for inductiond       .63 
Elective (yes) 7 (36.8) 2 (40.0) 5 (35.7)  
Uncontrolled hypertension 5 (26.3) 2 (40.0) 3 (21.4)  
Oligohydramnios 3 (15.8) 0 (0.0) 3 (21.4)  
Small for gestational age 1 (5.3) 0 (0.0) 1 (7.1)  
Nonreassuring fetal wellbeing 3 (15.8) 1 (20.0) 2 (14.3)  
Method of delivery (vaginal)e 16 (84.2) 4 (80.0) 12 (85.7) .62 
Prelabor C/S (yes)b 17 (19.1) 5 (20.0) 12 (18.8) .98 
Primary indication for prelabor C/Sd       .53 
Elective (yes) 12 (70.6) 4 (80.0) 8 (66.7)  
Uncontrolled hypertension (yes) 1 (5.9) 0 (0.0) 1 (8.3)  
Oligohydramnios (yes) 1 (5.9) 0 (0.0) 1 (8.3)  
Nonreassuring fetal wellbeing (yes) 1 (5.9) 0 (0.0) 1 (8.3)  
Malpresentation (yes) 1 (5.9) 0 (0.0) 1 (8.3)  
History of shoulder dystocia (yes) 1 (5.9) 1 (20.0) 0 (0.0)  
 M (SD) M (SD) M (SD)  
Maternal age (years) 26.4 (4.5) 27.3 (4.1) 26.1 (4.7) .26 
IL-1Ra production (pg/ml) 4873.4 (1402.4) 5160.1 (1264.6) 4761.4 (1446.6) .23 
IL-1b production (pg/ml) 41.7 (31.2) 44.4 (40.4) 40.7 (27.1) .86 
Gestation length (days) 273.8 (9.2) 271.2 (8.3) 274.8 (9.4) .06 
Note. C/S = cesarean section; IL = interleukin; Ra = receptor antagonist; SNP = single-nucleotide  
polymorphism. ap-values are for comparisons of women with IL1RN SNP rs2637988 GG genotype versus IL1RN 
SNP rs2637988 AA/AG genotypes using Student’s t tests, χ2 tests, or Fisher’s exact tests (when cells had fewer 
than five observations). bReason for presentation to Labor and Delivery suite. cIf presented with 
contractions/rutpure. dPrimary indications grouped into elective versus all other indications for  
group comparisons. eIf presented for induction. 
 
Among 89 participants, 64 possessed the minor allele (AA or AG genotype) and 25 lacked the minor 
allele (GG genotype). Major allele frequency was .52; minor allele frequency was .48. Observed allele 
frequencies were in Hardy–Weinberg equilibrium (p = .69). 
IL-1Ra production and IL-1β production were positively associated (rS = .31, p < .05). Neither IL-1Ra 
production nor IL-1β production were significantly correlated with days gestation at birth (see Tables; 
Supplemental Digital Content 1, http://links.lww.com/NRES/A214). 
Women with at least a bachelor’s degree had significantly higher IL-1Ra production (M = 5422, SD = 
1303 vs. M = 4671, SD = 1393, respectively; p = .02) and significantly higher IL-1β production (M = 
53.8, SD = 38.2 vs. M = 37.2, SD = 27.2, respectively, p = .03) than women without a bachelor’s degree. 
Women reporting private insurance also had significantly higher IL-1Ra production (M = 5425, SD = 
1345 vs. M = 4583, SD = 1357, respectively; p = .007) than women not reporting private insurance. 
Women with a history of birth before term gave birth 4.7 days earlier than women without a history of 
birth before term (M = 269.5, SD = 10.0 vs. M = 274.2, SD = 9.1, respectively). This difference was not 
statistically significant in our sample (p = .21). However, there is a large literature supporting an 
association between timing of birth in prior pregnancy and current pregnancy (Iams, 2014). To 
minimize potential for confounding, all linear regression models controlled for maternal education and 
insurance status. We did not control for history of birth before term in models for which allele status 
served as predictor, as allele status is a stable attribute that may contribute to repeated early births. 
History of birth before term was included as a covariate to ensure that this variable was not unduly 
influencing results when examining the relationship between IL-1β production and timing of birth. 
Allele Status and Timing of Birth 
Women with GG genotype for IL1RN SNP rs2637988 gave birth significantly earlier than women with 
AA/AG genotypes (b* = .21, p = .04; i.e., the total effect of IL1RN SNP rs2637988 allele status on timing 
of birth). Mean timing of birth was 271.2 days or 38 weeks 5.2 days (SD = 8.3; Mdn = 273; range: 252–
285) versus 274.8 days or 39 weeks 1.8 days (SD = 9.4 days; Mdn = 276.5; range: 239–288) for the GG 
and AA/AG groups, respectively (Figure 2). 
 
FIGURE 2: Back-to-back stem and leaf plot of timing of birth among women with IL1RN SNP rs2637988 
GG genotype versus women with IL1RN SNP rs2637988 AA/AG genotypes. Early-term, full-term, and 
late-term births are shaded. SNP = single-nucleotide polymorphism. 
 
IL-1Ra Production 
As shown in Table 2, there was no effect of allele status on IL-1Ra production, the assessed mediator 
(b* = .11, p = .31). Although there was a significant direct effect of IL1RN SNP rs2637988 allele status in 
predicting timing of birth, controlling for IL-1Ra production (b* = .21, p = .05), there was no indirect 
effect of IL1RN SNP rs2637988 allele status on timing of birth through IL-1Ra production, as evidenced 
by a 95% bootstrapping confidence interval of the indirect effect that contained 0 (ab = .006; 95% CI 
[−0.052, 0.131]). 
TABLE 2: Mediation Analysis: Effect of IL1RN SNP rs2637988 Allele Status on Days Gestation at Birth 
Through IL-1Ra Production 
  M: IL-1Ra 
productiona 
   Y: Gestation at 
birthb,c 
  
Predictor  Coeff. (SE) p  Coeff. (SE) p 
X: IL1RN SNP 
rs2637988 allele 
status                        
𝑎𝑎1 0.33 (0.322) .31 𝑐𝑐1’  0.56 (0.280)     .05 
M: IL-1Ra production   –  –  – 𝑏𝑏1  0.02  (0.094)  .85 
Covariate: maternal 
education  
 0.20  (0.487)  .69   0.31  (0.421)  .47 
Covariate: insurance 
status  
 −0.67  (0.458)  .15   0.62  (0.400)  .13 
Constant  𝑏𝑏0  5.17  (0.447)  < 
.001  
𝑏𝑏0  2.98  (0.620)  < 
.001 
Note. n = 89. 𝑎𝑎1 = coefficient assigned to X in the estimation of M; 𝑏𝑏1 = coefficient assigned to M in the 
estimation of Y; 𝑐𝑐1’  = coefficient assigned to X in the estimation of Y; Coeff. = coefficient; 𝑏𝑏0 = intercept; 
IL = interleukin; M = mediator; Ra = receptor antagonist; SE = standard error; SNP = single-nucleotide 
polymorphism; X = predictor. aR2 = .09, p = .04. bSquare root of reflected days gestation (i.e., −[days 
gestation] + 288 + 1). cR2 = .07, p = .18. 
IL-1β Production 
The relationship between IL-1Ra production and IL-1β production was conditional on IL1RN SNP 
rs2637988 allele status as evidenced by a significant interaction (b* = .93, p = .03). Specifically, women 
with GG genotype showed significantly less inhibition of IL-1β production for a unit positive difference 
in IL-1Ra production than women with AA/AG genotypes (Figure 3). To confirm that this finding was 
reflecting a difference in the relationship among IL-1Ra production and IL-1β production among 
women with GG versus AA/AG genotypes and not related to a main effect of allele status on IL-1β 
production, we also regressed IL-1β production onto allele status; no difference in IL-1β production 
was noted among women with GG versus AA/AG genotypes (b* = .004, p = .97). Finally, controlling for 
history of birth before term as well as maternal education and insurance status, greater IL-1β 
production was marginally associated with earlier birth (b* = .21, p = .05; Figure 4). 
 
FIGURE 3: IL1RN SNP rs2637988 allele status and inhibition of IL-1β production. Women with GG genotype 
showed less inhibition of IL-1β production for a unit positive difference in IL-1Ra production than women with 
AA/AG genotypes (b* = .93, p = .03). IL-1β production was normalized by square root transformation for 
analysis. SNP = single-nucleotide polymorphism. 
 
FIGURE 4: IL-1β production and timing of birth. Greater IL-1β production was associated with marginally earlier 
birth (b* = .21, p = .05). Days gestation at birth was normalized by reflecting the variable (i.e., −[days gestation] + 
288 + 1) followed by square root transformation for analysis. 
DISCUSSION 
Among generally healthy African American women, allele status at IL1RN SNP rs2637988 was 
significantly associated with timing of birth. Women with GG genotype gave birth earlier, with mean 
timing of birth falling within the early term range (37–38 weeks) among the GG group and full term 
range (39–40 weeks) among the AA/AG group (Spong, 2013). This finding extends the current 
literature, which has generally linked IL1RN variants to timing of birth among racially heterogeneous 
cohorts and focused on more extreme timing of birth outcomes (e.g., birth before term; Cui et al., 
2015; Dolan et al., 2010; Jones et al., 2012). We provide novel evidence that the relationship between 
IL1RN SNP rs2637988 and timing of birth does not appear to be mediated by an overall decrease in IL-
1Ra production upon immune challenge. In fact, women with GG genotype showed slightly, but not 
significantly, higher IL-1Ra production than women with AA/AG genotypes. This finding differs from 
that reported in a study of healthy adults in which GG genotype for this SNP was associated with lower 
mononuclear cell IL-1Ra mRNA (Korthagen et al., 2012). However, comparisons are difficult because of 
differences in populations under study and laboratory methodologies. Our mediation model also 
suggests that ex vivo production of IL-1Ra in pregnancy is a poor predictor of timing of birth. This is 
consistent with some (Brou et al., 2012; Genc et al., 2004), but not all (Heng, Di Quinzio, Permezel, 
Rice, & Georgiou, 2008; Ruiz et al., 2012), studies evaluating circulating cytokine concentrations within 
various maternal fluids during pregnancy and labor. 
We also investigated a more complex potential pathway. We hypothesized that the IL1RN SNP 
rs2637988 risk variant may result in decreased inhibition of IL-1β production during the inflammatory 
immune response and greater IL-1β production, in turn, would predict earlier birth. Our findings lend 
support to this pathway. We measured total ex vivo IL-1Ra and IL-1β production following 4 hours of 
whole blood incubation with LPS, which aimed to mimic the in vivo conditions of a bacterially induced 
inflammatory immune response while minimizing participant risk. Consistent with previous reports 
among pregnant and nonpregnant samples, IL-1Ra and IL-1β production covaried (Heng et al., 
2014; Langereis et al., 2011). However, inhibition of IL-1β by IL-1Ra during the inflammatory immune 
response appeared to be compromised among women with GG genotype, which is important 
considering that greater IL-1β production went on to predict earlier birth. These findings are consistent 
with several studies suggesting that the manner in which IL-1Ra and IL-β interact is important in 
maintaining pregnancy. For example, a decrease in IL-1Ra levels has been reported alongside a rise in 
IL-1β levels sampled from cervicovaginal fluid as spontaneous term labor approaches (Heng et al., 
2014). A diminished cervicovaginal IL-1Ra/IL-1β ratio in the second trimester has also been linked to 
increased risk for future birth before term (Genc et al., 2004). 
Although this study provides novel data regarding biological pathways associated with timing of birth 
among African American women, there are several important limitations. First, among our sample, the 
rate of birth prior to full term (39 weeks) was 34.8% compared to a national rate of 40.4%, and the rate 
of birth prior to term (37 weeks) was 5.6% compared to a national rate of 13.2% (Hamilton et al., 
2015). This difference is not surprising given this study’s exclusion of women with behaviors (e.g., 
tobacco use), chronic conditions (e.g., diabetes mellitus), and complications of pregnancy (e.g., 
gestational diabetes, preeclampsia) associated with inflammation but also strongly related to early 
birth. For example, the odds of birth before term are approximately 4.5 times greater during 
pregnancy complicated by preeclampsia versus normotensive pregnancy (Davies, Bell, & Bhattacharya, 
2016). Although this approach enhanced internal validity of findings, greater variability in the 
distribution of timing of birth would improve ability to detect relationships and confirm null findings. 
Although data points of large influence were not present according to Cook and Weisberg’s definition 
(Cook’s d > 1) (Cook & Weisberg, 1982), replication also remains critical in strengthening 
generalizability and ensuring unique cases were not influencing results. 
Furthermore, 59.6% of study participants presented to labor and delivery following onset of 
contractions or rupture of membranes, whereas 40.4% presented to labor and delivery to undergo 
induction or prelabor cesarean section. Clearly, the high rates of birth that are not preceded by labor 
processes decrease the ability to assess pathways to spontaneously initiated birth, the primary aim of 
the study. However, induction and prelabor cesarean sections affect more than 50% of births in the 
United States, and inclusion of these cases offers some benefit in terms of generalizability and 
hypothesis generation (Laughon et al., 2012; Zhang et al., 2010). It is certainly plausible that an 
impaired inflammatory immune response during pregnancy may contribute to the development of 
spontaneously initiated early birth as well as complications of pregnancy that increase risk for 
medically-indicated early birth. For example, although this study excluded women with preeclampsia 
due to known inflammatory features, a growing body of literature implicates inflammation in 
additional hypertensive disorders (Li et al., 2016; Tangerås et al., 2015). The role of IL1RN and IL-1β 
inhibition in the development of various complications of pregnancy with hypothesized immune 
components is worth exploring. 
The current study found that women with GG genotype of IL1RN SNP rs2637988 gave birth 
significantly earlier than women with AA/AG genotypes. 
To summarize, the current study found that women with GG genotype of IL1RN SNP rs2637988 gave 
birth significantly earlier than women with AA/AG genotypes. This relationship was not mediated by IL-
1Ra production; however, women with GG genotype showed decreased inhibition of IL-1β production. 
Greater IL-1β production, in turn, was marginally associated with earlier birth in this small, healthy 
sample. This work confirms IL1RN as a noteworthy gene involved in timing of birth among African 
American women and implicates impaired IL-1β inhibition during the inflammatory immune response 
as a potential mechanism underlying early birth. The molecular underpinnings linking IL1RN genetic 
variants to decreased IL-1β inhibition remain to be determined. Our findings may reflect linkage 
disequilibrium among the assessed tagging SNP and additional allele(s) of the IL-1 gene cluster or IL1RN 
genetic variants may result in, for example, allosteric switching or hydrogen bonding disruptions 
capable of transforming IL-1Ra from a competitive inhibitor to a partial proinflammatory agonist 
(Greenfeder et al., 1995; Hailey, Capraro, Barkho, & Jennings, 2013). These are interesting possibilities 
to consider in future mechanistic work. 
It is also critical that future studies apply advances in mechanistic knowledge to the development of 
clinical applications, namely biological screening tools and preventive interventions. Considering that 
growing evidence characterizes early birth as a syndrome preceded by diverse instigating biological 
pathways (Esplin et al., 2015; Myatt et al., 2012), we propose that clinical tools be developed to predict 
and prevent the instigating pathway (e.g., inflammation) as opposed to the shared syndromic features 
(e.g., cervical dilation, uterine contraction, membrane rupture). By mimicking a potential in vivo 
response to immune challenge, our measure of ex vivo IL-1β production may have potential to predict 
future risk for inflammatory early birth among African American women not yet experiencing signs and 
symptoms of labor. Women known to be at risk for early birth via the inflammatory pathway may reap 
particular benefit from preventive interventions with anti-inflammatory properties, including 
progesterone and omega-3 fatty acid supplementation (Alvarez-Curto & Milligan, 2016; Flores-
Espinosa et al., 2014). Indeed, decades of research in early birth prevention have strongly suggested 
that one size does not fit all. For example, progesterone supplementation is quite beneficial among 
women with a singleton pregnancy and prior birth before term but harmful among women with 
multiple gestation (O'Brien & Lewis, 2016). There is incredible opportunity for precision approaches to 
usher in an era of risk prediction and targeted prevention in the context of prenatal care. Clinical tools 
designed with racial differences in biological pathways in mind may also be key to eliminating racial 
disparities in birth outcomes. 
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